Multiple myeloma associated IgA pemphigus: treatment with bortezomib- and lenalidomide-based regimen

Clin Lymphoma Myeloma Leuk. 2011 Dec;11(6):517-20. doi: 10.1016/j.clml.2011.06.014.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage
  • Bortezomib
  • Female
  • Humans
  • Immunoglobulin A / blood*
  • Lenalidomide
  • Middle Aged
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy*
  • Pemphigus / complications*
  • Pemphigus / immunology
  • Pyrazines / administration & dosage
  • Remission Induction
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives

Substances

  • Boronic Acids
  • Immunoglobulin A
  • Pyrazines
  • Thalidomide
  • Bortezomib
  • Lenalidomide